Search | Page 11 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Myelodysplastic syndromes

    ... The myelodysplastic syndromes (MDS) represent a heterogeneous group of clonal hematopoietic ...

    Research Article last updated 07/20/2018 - 5:15pm.

  2. Can iron overload in patients with lower-risk myelodysplastic syndromes be reduced using erythropoiesis-stimulating agents?

    ... Iron overload (IOL) portends inferior outcome in myelodysplastic syndromes (MDS). Erythropoiesis-stimulating agents (ESA) may reduce ...

    Research Article last updated 07/20/2018 - 5:15pm.

  3. Specific Plasma Autoantibody Reactivity in Myelodysplastic Syndromes

    ... Increased autoantibody reactivity in plasma from Myelodysplastic Syndromes (MDS) patients may provide novel disease signatures, and possible ...

    Research Article last updated 07/20/2018 - 5:15pm.

  4. Methylation of Promoters of microRNAs and their Host Genes in Myelodysplastic Syndromes.

    ... ABSTRACT Myelodysplastic syndromes (MDS) are a group of hematopoietic malignancies characterized by ...

    Research Article last updated 07/20/2018 - 5:15pm.

  5. Impact of iron overload in myelodysplastic syndromes.

    ... Anaemia is prevalent in patients with myelodysplastic syndromes (MDS), and most patients with MDS receive regular red blood ...

    Research Article last updated 07/20/2018 - 5:14pm.

  6. Should elderly patients with higher-risk myelodysplastic syndromes undergo allogeneic hematopoietic stem cell transplantation?

    ... transplantation in older patients with de novo myelodysplastic syndromes : an international collaborative decision analysis. J. Clin. ...

    Research Article last updated 07/20/2018 - 5:15pm.

  7. Genome sequencing in myelodysplastic syndromes: can molecular mutations predict benefit from hypomethylating agent therapy?

    ... mutations predict response to hypomethylating agents in myelodysplastic syndrome patients. Blood 2014 Oct 23;124(17):2705-12. Patients with myelodysplastic syndromes (MDS) have clinically variable courses even within the same ...

    Research Article last updated 07/20/2018 - 5:15pm.

  8. Iron chelation therapy in myelodysplastic syndromes.

    ... iron chelation therapy (ICT) in patients with myelodysplastic syndromes (MDS), evaluation of the role of different agents available for ...

    Research Article last updated 07/20/2018 - 5:14pm.

  9. Mesenchymal stromal cell density is increased in higher grade myelodysplastic syndromes and independently predicts survival

    ... underwent bone marrow biopsy to evaluate for myelodysplastic syndromes (MDS). METHODS: CD271+ MSC density was quantitated by ...

    Research Article last updated 07/20/2018 - 5:15pm.

  10. Interpreting new molecular genetics in myelodysplastic syndromes

    ... The myelodysplastic syndromes (MDS) are a clinically and cytogenetically heterogeneous group of ...

    Research Article last updated 07/20/2018 - 5:14pm.